In this podcast moderated by Dr Michael Kalos, Janssen Oncology, you will hear a panel discussion from the 2019 IO Combinations 360° conference. Topic points include:

What are the new opportunities in cell therapy for combinations?
What the challenges are going to be with the microenvironment?
What is being done to engineer cell therapy?
How do you develop CARs and TCRs that deliver payloads?
How do you manufacture all of this beyond mouse models to
figure out how to effectively do this in patients?
How do you actually go about designing trials and testing
hypothesis?
How do you create the regulatory framework to do these types
of studies?
How do you engage with regulatory agencies to get these things
moving?

Panelists include:

Sharon Benzeno, PhD, MBA, Adaptive Biotechnologies
Chaohong Fan, MD, PhD, FDA
Bruce Levine, PhD, University of Pennsylvania
Mark Stewart, PhD, Friends of Cancer Research
Bahram Valamehr, PhD, Fate Therapeutics

To learn more about the upcoming IO Combinations 360° conference please visit, www.iocombinations360.com

New Opportunities for Cell Therapy Combinations

Share

Embed